Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sauerberg

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Neuroreport|December 17, 1998
Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned ratsA Fink-Jensen, P Kristensen, H E Shannon, et al.
Journal of Medicinal Chemistry|February 17, 1998
1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonistsJ S Ward, L Merritt, D O Calligaro, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in ratsH E Shannon, J C Hart, F P Bymaster, et al.
Schizophrenia Research|May 10, 2001
The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidanceT Rasmussen, A Fink-Jensen, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesicM D Swedberg, M J Sheardown, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232)F P Bymaster, D T Wong, C H Mitch, et al.
European Journal of Pharmacology|October 17, 1998
Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane F P Bymaster, H E Shannon, K Rasmussen, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptorsH E Shannon, F P Bymaster, D O Calligaro, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activationP Sauerberg, L Jeppesen, P H Olesen, et al.
European Journal of Pharmacology|August 26, 2000
Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive miceT Rasmussen, P Sauerberg, E B Nielsen, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Neuroreport|December 17, 1998
Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned ratsA Fink-Jensen, P Kristensen, H E Shannon, et al.
Journal of Medicinal Chemistry|February 17, 1998
1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonistsJ S Ward, L Merritt, D O Calligaro, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in ratsH E Shannon, J C Hart, F P Bymaster, et al.
Schizophrenia Research|May 10, 2001
The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidanceT Rasmussen, A Fink-Jensen, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesicM D Swedberg, M J Sheardown, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232)F P Bymaster, D T Wong, C H Mitch, et al.
European Journal of Pharmacology|October 17, 1998
Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane F P Bymaster, H E Shannon, K Rasmussen, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptorsH E Shannon, F P Bymaster, D O Calligaro, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activationP Sauerberg, L Jeppesen, P H Olesen, et al.
European Journal of Pharmacology|August 26, 2000
Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive miceT Rasmussen, P Sauerberg, E B Nielsen, et al.
Pageof 4